{"product_id":"budesonide-inhalation-suspension-0-5-mg-2-ml-nephron-0-5-ml-x-6-vials-rx","title":"Budesonide Inhalation Suspension 0.5 mg\/2 mL Nebulizer Solution 0.5 mL x 30 Vials (RX)","description":"\u003ch1\u003eBudesonide Inhalation Suspension (0.5 mg\/2 mL Nebulizer Solution)\u003c\/h1\u003e\n\u003cp\u003eBudesonide inhalation suspension is a \u003cstrong\u003ecorticosteroid (inhaled steroid)\u003c\/strong\u003e formulation used to prevent and control airway inflammation. Each 2 mL unit-dose ampoule (respule) contains 0.5 mg budesonide as a sterile suspension for nebulization. Budesonide is a potent non-halogenated glucocorticoid that binds lung cell steroid receptors, reducing inflammatory mediator release and airway swelling. It is used on a regular schedule (daily) to control asthma and related conditions, but it has \u003cstrong\u003eno immediate bronchodilator\u003c\/strong\u003e effect – it will \u003cstrong\u003enot relieve an acute asthma attack\u003c\/strong\u003e. Instead, by suppressing chronic inflammation in the airways, inhaled budesonide decreases asthma symptoms and exacerbations over time.\u003c\/p\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eBudesonide is an \u003cstrong\u003einhaled glucocorticoid\u003c\/strong\u003e. Once inhaled, it penetrates airway cells and binds intracellular glucocorticoid receptors, modulating gene transcription. This leads to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDecreased airway inflammation:\u003c\/strong\u003e Inhibits production of inflammatory cytokines, chemokines and leukotrienes; reduces airway mucosal edema, hyperreactivity, and mucus secretion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLocal effect:\u003c\/strong\u003e Since it is inhaled directly to the lungs, most of its effect is local, minimizing systemic distribution. Only a small fraction reaches the bloodstream, making systemic side effects far less common than with oral steroids.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOver days to weeks of regular use, these anti-inflammatory actions improve lung function and reduce asthma symptoms. (Patients are often advised that benefits may take several days to appear.) Budesonide has little acute effect on bronchospasm by itself; therefore, a short-acting bronchodilator (rescue inhaler) is required to relieve sudden asthma attacks.\u003c\/p\u003e\n\u003ch2\u003eUses\u003c\/h2\u003e\n\u003cp\u003eBudesonide 0.5 mg inhalation suspension is indicated mainly for \u003cem\u003emaintenance therapy\u003c\/em\u003e in respiratory conditions \u003cstrong\u003eneeding inhaled corticosteroid therapy\u003c\/strong\u003e. Key uses include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAsthma (Bronchial Asthma, Persistent)\u003c\/strong\u003e – Chronic management to prevent symptoms. It is used in patients whose asthma requires daily controller medication. It helps control mild-to-severe asthma by reducing inflammation and airway hyperresponsiveness. Budesonide inhalation suspension is often chosen for younger children or patients who cannot coordinate inhaler use, since it is given by nebulizer. \u003cem\u003eNote:\u003c\/em\u003e It is \u003cem\u003enot\u003c\/em\u003e a rescue medication; it will not stop an ongoing asthma attack.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCroup (Acute Viral Laryngotracheobronchitis)\u003c\/strong\u003e – Budesonide nebulizer is recommended for infants\/children hospitalized with moderate-to-severe viral croup to reduce upper airway swelling. A single dose (often 0.5–1 mg) can ease symptoms as adjunct therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExercise-Induced Asthma (Prophylaxis)\u003c\/strong\u003e – While beta-agonists are first-line for exercise bronchospasm, regular use of inhaled steroids like budesonide can reduce hyperresponsiveness and frequency of exercise-induced symptoms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther Inflammatory Airway Disorders:\u003c\/strong\u003e Occasionally used off-label for reactive airway dysfunction or recurrent wheezing in young children, as part of asthma management. In practice, it may also be used in chronic obstructive pulmonary disease (COPD) when inhaled corticosteroids are indicated (though other ICS like fluticasone or combination products are more common).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeaning from Oral Steroids:\u003c\/strong\u003e High-dose inhaled budesonide can allow reduction of systemic steroids in severe asthma cases, though careful supervision is needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote\u003e\n\u003cp\u003e\u003cem\u003eIn all cases, budesonide inhalation suspension is a long-term controller\/preventive therapy. Patients should not use it during an acute asthma attack – a short-acting inhaler (e.g. albuterol) is needed for rescue).\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003ch2\u003eAdministration and Dosing\u003c\/h2\u003e\n\u003cp\u003eBudesonide inhalation suspension comes in 2 mL unit-dose ampoules (respules) of 0.25 mg or 0.5 mg strength (0.25 mg\/2 mL or 0.5 mg\/2 mL). It must be administered \u003cstrong\u003evia nebulizer\u003c\/strong\u003e: the respirule is opened and its contents poured into the nebulizer reservoir. Then the patient inhales the mist produced by a pneumatic jet nebulizer, usually using a mouthpiece or a face mask. Important points:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo swallowing:\u003c\/strong\u003e This suspension is \u003cem\u003efor inhalation only\u003c\/em\u003e. Do not swallow the solution .\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not mix medications:\u003c\/strong\u003e Do not combine budesonide suspension with other drugs or diluents in the nebulizer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShake gently:\u003c\/strong\u003e The unit-dose should be gently shaken before administration to disperse the steroid.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRinse mouth:\u003c\/strong\u003e After each dose, rinse the mouth vigorously and spit out the water. This helps prevent local steroid effects (hoarseness, candidiasis).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing Frequency:\u003c\/strong\u003e Budesonide inhalation suspension is usually given \u003cstrong\u003etwice daily\u003c\/strong\u003e (morning and evening) in divided doses for asthma maintenance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTypical Doses:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cem\u003eChildren (3 months to 12 years):\u003c\/em\u003e Maintenance doses typically 0.25–0.5 mg (1 respule of 0.5 mg) twice daily.\u003c\/li\u003e\n\u003cli\u003e\n\u003cem\u003eAdults and Adolescents (≥12 years):\u003c\/em\u003e Maintenance usually 0.5–1 mg twice daily).\u003c\/li\u003e\n\u003cli\u003e\n\u003cem\u003eInfants (down to ~3 months):\u003c\/em\u003e Doses are similar to young children (0.25–0.5 mg BID), adjusted by physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cem\u003eAcute Croup:\u003c\/em\u003e Often a single dose of 0.5–1 mg nebulized as needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTitration:\u003c\/strong\u003e The minimal effective dose to maintain symptom control should be used. Dosing may be increased for severe asthma or during attack prevention, then tapered to maintenance. For example, during an asthma exacerbation when switching off oral steroids, physicians may give higher doses of budesonide nebulizer initially.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Budesonide is long-term therapy. If switching from oral steroids, taper gradually (carry a “steroid emergency card”). Do \u003cem\u003enot\u003c\/em\u003e discontinue abruptly if you have been on chronic steroids.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eVeterinarians or other specialists may use different regimens; always follow physician orders.\u003c\/p\u003e\n\u003ch2\u003eSide Effects and Adverse Reactions\u003c\/h2\u003e\n\u003cp\u003eBecause budesonide is given by inhalation, most side effects are \u003cstrong\u003elocal to the oropharynx and respiratory tract\u003c\/strong\u003e. Systemic effects are uncommon at usual inhaled doses but can occur with high doses or prolonged use. Key adverse reactions include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOropharyngeal Candidiasis (Thrush):\u003c\/strong\u003e Steroid mist can cause a yeast overgrowth in the mouth or throat, leading to white patches, soreness, or redness. Patients are advised to rinse their mouth after dosing to reduce this risk. If thrush occurs, an antifungal mouthwash\/gel may be prescribed, but inhaled steroids should be continued.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHoarseness and Throat Irritation:\u003c\/strong\u003e Treating the lungs with steroid aerosol often causes voice changes, coughing, or a sore throat. A few patients notice mild cough or shortness of breath immediately after nebulization. Proper technique and mouth rinsing can mitigate these effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCough and Bronchospasm:\u003c\/strong\u003e Rarely, nebulizing the suspension may transiently worsen cough or cause bronchospasm (tightening of the airways). If this happens, stop treatment and use a bronchodilator.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeadache or Miscellaneous:\u003c\/strong\u003e Some patients report headache, nausea, or dizziness, but these are infrequent.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNasal Congestion:\u003c\/strong\u003e Mild upper respiratory stuffiness or sneezing can occur as part of local irritation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSystemic Steroid Effects (at high dose or long term):\u003c\/strong\u003e Although inhaled budesonide is much less systemic than oral steroids, high-dose or prolonged therapy can still produce systemic glucocorticoid effects:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdrenal Suppression:\u003c\/strong\u003e Rare with standard inhaled doses, but possible if very high doses are used or if combined with other steroids. Patients with unusual stress (infection, surgery) may need supplemental steroids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Suppression:\u003c\/strong\u003e Chronic use of inhaled steroids in children can slow growth rate. Budesonide carries a low risk, but children’s height should be monitored. If growth slows, doctors may adjust therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone Density:\u003c\/strong\u003e Long-term steroids may reduce bone mineral density. Patients on chronic high-dose inhaled steroids should ensure adequate calcium\/vitamin D and have bone health monitored.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOcular:\u003c\/strong\u003e Prolonged use may slightly increase the risk of cataracts or glaucoma. Eye exams are recommended if therapy is extended.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic:\u003c\/strong\u003e Effects like weight gain or Cushingoid appearance are very uncommon at inhaled doses, but can occur with super-high dosages over time. Naïve patients on high chronic doses might rarely manifest features of Cushing’s syndrome (moon face, obesity).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfections:\u003c\/strong\u003e By dampening local immunity, inhaled steroids may theoretically increase risk of respiratory infections (pneumonia) or make existing infections worse. Caution in active lung infections or tuberculosis. (Indeed, patients on chronic steroids should avoid exposure to chickenpox\/measles.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e Budesonide allergy is rare. If it occurs, discontinue and treat accordingly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn summary, budesonide inhalation’s side effect profile is much milder than systemic steroids. The most common issues are oral thrush and throat irritation. Ensuring correct inhalation technique (nebulizing fully) and mouth rinsing are key to minimizing adverse effects.\u003c\/p\u003e\n\u003ch2\u003ePrecautions and Warnings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot for Acute Asthma:\u003c\/strong\u003e Always have a short-acting bronchodilator on hand. Budesonide is a controller, \u003cem\u003enot\u003c\/em\u003e a rescue medication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMask\/Inhaler Use:\u003c\/strong\u003e If using a mask, ensure a good seal. Spillage wastes medication. If a face mask is used, patients should have the mask removed and face washed after treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSwitching Steroids:\u003c\/strong\u003e Patients on systemic (oral or IV) steroids should not be abruptly converted to inhaled budesonide without a taper. The inhaled dose provides much less systemic steroid effect, and adrenal insufficiency can occur. Carrying a steroid emergency card is recommended.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcurrent Infections:\u003c\/strong\u003e Avoid initiating in untreated tuberculosis or fungal infections of the respiratory tract; steroids can worsen these infections. Use caution in immunocompromised patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEye Conditions:\u003c\/strong\u003e Monitor for vision changes, cataracts or glaucoma if on long-term therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy\/Breastfeeding:\u003c\/strong\u003e Budesonide (inhaled) falls into FDA Pregnancy Category B. The systemic risk is low, but steroids do cross the placenta and appear in breast milk in small amounts. Use only if clearly needed. (In some cases of severe asthma, benefits outweigh risks — consult an obstetrician and weigh benefits vs. small fetal exposure.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren:\u003c\/strong\u003e Monitor growth by regular height measurements. The lowest effective dose should be used.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eElderly:\u003c\/strong\u003e Older adults are more prone to bone\/joint issues. Use caution and monitor bone health if long-term use is anticipated.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug Interactions:\u003c\/strong\u003e Few clinically important drug interactions, but note that strong CYP3A4 inhibitors (such as ketoconazole or ritonavir) can markedly increase budesonide blood levels, potentially enhancing side effects. Also, avoid concurrent systemic steroids if possible, or adjust doses to avoid Cushing’s syndrome.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSummary\u003c\/h2\u003e\n\u003cp\u003eBudesonide inhalation suspension 0.5 mg\/2 mL is a \u003cstrong\u003enebulized corticosteroid\u003c\/strong\u003e used primarily for asthma control and related respiratory inflammation. It is given by a special nebulizer device and works over time to reduce lung swelling. Its main indication is persistent asthma (especially in young children), and it is sometimes employed in acute pediatric croup. Patients typically inhale the 2 mL suspension once or twice daily as prescribed. Common side effects are local (throat irritation, cough, oral thrush); systemic side effects are rare at usual doses. Nonetheless, long-term or high-dose use can cause steroid-related effects (e.g. suppressed growth in children), so patients are monitored and given the lowest effective dose. Because it is inhaled, budesonide has a safer systemic profile than oral steroids. All use should follow a healthcare provider’s instructions.\u003c\/p\u003e","brand":"Nephron Pharmaceuticals","offers":[{"title":"Default Title","offer_id":53541547442544,"sku":"00487-9701-30P","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Nephron-0048-79701-30-Budesonide-Inhalation-Suspension-0.5-m.jpg?v=1775483911","url":"https:\/\/www.mountainside-medical.com\/products\/budesonide-inhalation-suspension-0-5-mg-2-ml-nephron-0-5-ml-x-6-vials-rx","provider":"Mountainside Medical","version":"1.0","type":"link"}